Advertisement

Topics

Daiichi Sankyo announces top─line results from phase 3 trial of mirogabalin in patients with post─herpetic neuralgia & fibromyalgia

08:14 EDT 1 Jul 2017 | PharmaBiz

Daiichi Sankyo Company has announced top─line results from NEUCOURSE, a phase 3 clinical trial in patients with post─herpetic neuralgia, and the ALDAY phase 3 clinical trials in patients with fibromyalgia.

Original Article: Daiichi Sankyo announces top─line results from phase 3 trial of mirogabalin in patients with post─herpetic neuralgia & fibromyalgia

NEXT ARTICLE

More From BioPortfolio on "Daiichi Sankyo announces top─line results from phase 3 trial of mirogabalin in patients with post─herpetic neuralgia & fibromyalgia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...